Intelligence · Clinical Development
Pipeline search results
Programs matching “acute-myeloid-leukemia” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 134 pipeline programs matching "acute-myeloid-leukemia" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Arsenic trioxide
Teva Pharma GmbH
Acute Myeloid Leukemia
1 trial -
Asparaginase
Children's Hospital of Fudan University
Acute Myeloid Leukemia
1 trial -
Azacitidine Combined With Venetoclax and ATRA group
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
CPX-351
Jazz Pharmaceuticals Ireland Limited
High Risk Acute Myeloid Leukemia
1 trial -
Cytarabine
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial -
DAC-HAAG-02
Hospital Authority, Hong Kong
Acute Myeloid Leukemia
1 trial -
Decitabine
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Decitabine
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia, Adult
1 trial -
Decitabine plus HAAG regimen
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Dociparstat
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial -
Gilteritinib
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia (AML)
1 trial -
HVA
The First People's Hospital of Lianyungang
Newly Diagnosed Acute Myeloid Leukemia With High Risk
1 trial -
IAC regimen
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Intermediate-dose Cytarabine in Combination with Venetoclax
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia (AML)
1 trial -
Iomab-B
Actinium Pharmaceuticals
Acute Myeloid Leukemia
1 trial -
Mitoxantrone Hydrochloride Liposome
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia (AML)
1 trial -
Revumenib
United Therapeutics Europe Ltd
Acute Myeloid Leukemia, Adult
1 trial -
Revumenib
Syndax Pharmaceuticals
Acute Myeloid Leukemias
1 trial -
Sorafenib
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Venetoclax
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Venetoclax 400
United Therapeutics Europe Ltd
Acute Myeloid Leukemia
1 trial -
Ziftomenib
Kura Oncology
Acute Myeloid Leukemia (AML)
1 trial -
gilteritinib
Astellas Pharma Inc
Acute Myeloid Leukemia (AML)
1 trial -
ADCT-301
ADC Therapeutics SA
Acute Myeloid Leukemia (AML)
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.